Two of Astellas Pharma most sold products increase the risk of PRES in already vulnerable patients
Posterior reversible encephalopathy syndrome (PRES) is an acute neurotoxic syndrome characterized by headache, impairment of consciousness, seizures, visual disturbances, and neurological deficits3. Long PRES can lead to death9;p3.
Astellas Pharm...
Register to read the full analysis —or— Upgrade to access more features
#illnesses
#side-effects
#negative health
#cancer
#PRES
Actual Direct Impact
Share this Analysis
Keen to rectify an issue with this analysis?
Report issue
There is no comment yet.